openPR Logo
Press release

Increasing Consumption of Antibiotics Worldwide to fuel Demand for Microbiology Culture

11-22-2017 10:01 AM CET | Health & Medicine

Press release from: TMR - Research Reports

Increasing Consumption of Antibiotics Worldwide to fuel Demand

Although the top four players - Sigma-Aldrich, Thermo Fisher, Merck Millipore, and Becton, Dickinson and Co. - accounted for a share of 52.7% in the global market for microbiology culture in 2014, the presence of a large pool of international as well as regional players points toward a moderately fragmented structure of the market’s competitive landscape, finds a report by Transparency Market Research (TMR). The degree of competition, however, is high within the market and participants are aggressively focused on making new discoveries and reaching new breakthroughs in order to gain a competitive edge.

Read Report Overview @ https://www.transparencymarketresearch.com/microbiology-culture-market.html

TMR recommends players to shift their focus towards emerging economies such as Brazil, India, and China, as they hold immense untapped opportunities for future growth.

“The rapid rise in the demand for antibiotics has had a lasting effect on the practice of microbiology culture,” states an analyst at TMR. Antibiotics are secondary metabolites produced by microorganisms and utilized in the treatment of a number of bacterial and protozoan infections. Mostly, antibiotics are naturally occurring; however, the quantity available in the natural environment is far less than the required quantity for large-scale production. Hence, microbes are cultured under controlled conditions to increase their biomass and to separate the antibiotics from them.

Request Sample Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=3232

According to Lancet Infectious Diseases Commission, the consumption of antibiotic drugs witnessed a rise by 36% during the period from 2000 to 2010 with the BRICS nations holding a share of 76% of this increase. The high prevalence of infectious diseases, the rising healthcare expenditure, and the increasing access to antibiotic drugs have driven the consumption of antibiotics in these countries since the last decade and are likely to do so in the years to come. Owing to this, the demand for microbial culture is also expected to increase significantly over the next few years.

On the other hand, the market may face severe challenges from the high costs associated with culture media and the continual functioning of fermentation vessel over several weeks. The difficulty in the identification of alternative nutrient sources for the growth of various microorganisms in order to meet the specific requirements and to reduce the cost of large-scale fermentation are also expected to hamper microbial culture practices to some extent in the near future.

The advent of recombinant technology, however, is anticipated to offer lucrative growth opportunities to players operating in the global market for microbiology culture over the forthcoming years.

Request Microbiology Culture Market Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=3232

On account of the increased funding by several governments in the field of microbiology, North America and Europe has acquired the first two positions in the global microbiology culture market. In 2014, North America topped the list with a share of 35.4%, whereas Europe closely followed with 32.0%. Analysts expect North America to remain the key regional market; however, Asia Pacific is likely to report the growth at the fastest cumulative average rate of 6.80% between 2015 and 2023.

Bacterial culture headed the global market in 2014 and is expected to continue to lead in the near future. Complex media is likely to remain the most preferred culture media over the next few years.

On the whole, the opportunity in the global market for microbial culture is likely to rise at a CAGR of 5.90% between 2015 and 2023, increasing from US$4.5 bn in 2014 to an estimated value of US$7.6 bn by the end of the forecast period.

Buy Full Microbiology Culture Market Report @ https://www.transparencymarketresearch.com/checkout.php?rep_id=3232<ype=S

About TMR

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Increasing Consumption of Antibiotics Worldwide to fuel Demand for Microbiology Culture here

News-ID: 827796 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Antibiotics

Cephalosporin Antibiotics API market: Key Tactics by Players to Consolidate Pres …
" The Cephalosporin Antibiotics API global market is thoroughly researched in this report, noting important aspects like market competition, global and regional growth, market segmentation and market structure. The report author analysts have estimated the size of the global market in terms of value and volume using the latest research tools and techniques. The report also includes estimates for market share, revenue, production, consumption, gross profit margin, CAGR, and other key
Cephalosporin Antibiotics API Market to Witness Huge Growth by Key Players: NCPC …
The Cephalosporin Antibiotics API report compiles the market information depending upon market development and growth factors, optimizing the growth path. In addition, it highlights the strategies and market share of the leading vendors in the particular market. The report follows a robust research methodology model that helps to make informed decisions. It obtains both qualitative and quantitative market information supported by primary research. The Cephalosporin Antibiotics API research report recognizes and
Antibiotics Market Excellent Growth 2021 Top Key Players | Antibiotics market a …
Antibiotics Market Overview: The market research report on the Global Antibiotics Market offered by Straits Research, analyses the major opportunities, CAGR, yearly growth rates to help the readers to understand the qualitative and quantitative aspects of the Global Antibiotics Market. The competition landscape, company overview, financials, recent developments and long-term investments related to the Global Antibiotics Market are mentioned in this report. Various parameters have been studied while estimating the market size. The revenue
Global Antibiotics Market Overview 2019-2025
The global antibiotics market is expected to reach USD 40.78 billion by 2025. Increasing prevalence of infectious diseases worldwide is a major factor driving the global antibiotics market. Since the discovery of antibiotics in the early 20th century, these have been an essential tool in treating the massive burden of infectious diseases worldwide. Yet antimicrobial resistance or AMR is increasingly threatening the effectiveness of antibiotics, which may restrain their use. Major
Macrolide Antibiotics Market Greater Revenue Share by 2026(Macrolide Antibiotics …
Macrolide Antibiotics are bacteriostatic in nature with a broad spectrum of activity against many gram-positive bacteria. Macrolide Antibiotics are primarily useful in treating soft tissue, respiratory condition, sexually transmitted and atypical mycobacterial infections. Macrolide Antibiotics also possess anti-inflammatory and immunomodulatory effects which are used for certain health conditions. Macrolide Antibiotics are considered to be both first line and second line of treatment, it mainly depends on the conditions it is
Global MRSA Antibiotics Market: Scenario 2025
“Global MRSA Antibiotics Industry Report" is an expert and in-depth analysis of key business and future development prospects, key determinants and restrictions, profiles of major market players, segmentation and forecasting. The study offers a comprehensive qualitative analysis of the industry's growth parameters, the current state of the market in terms of analysis of key economic situations and macroeconomic analysis. The analysis highlights the growth opportunities of key market segments along